MGIM
FOLD

M&G Investment Management’s Amicus Therapeutics FOLD Stock Holding History

M&G Investment Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$9.95M Buy
+710,557
New +$8.07M 0.04% 202

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

M&G Investment Management's FOLD Position: Q4 2023 in Review

M&G Investment Management opened a new position in Amicus Therapeutics (FOLD) in Q4 2023: 710,557 shares worth $9.95M. The stake represents 0.04% of the portfolio and ranks #202 among its holdings.

228 funds tracked by Wall St. Rank hold FOLD as of Q4 2023.

  • M&G Investment Management held 710,557 shares of Amicus Therapeutics worth $9.95M as of Q4 2023.
  • Amicus Therapeutics was a new M&G Investment Management position in Q4 2023.
  • Amicus Therapeutics made up 0.04% of M&G Investment Management's portfolio in Q4 2023, its #202 holding.
  • 228 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2023.

Based on M&G Investment Management's 13F filing for Q4 2023, filed 8 Feb 2024.